PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12393025-7	2002	The results showed a significantly higher degree of decrease in platelet counts and elevated serum TPO in patients receiving CIFN 9 or 3 &mgr;g as compared with placebo at week 12 and week 24 of treatment, respectively.	Adenosine Monophosphate	138-141	thrombopoietin	Homo sapiens	99-102	
11514400-4	2001	METHODS: We measured TPO (R&D Systems) in serum of 160 thrombocytopenic patients referred to our department for platelet life span isotopic studies.	Adenosine Monophosphate	28-31	thrombopoietin	Homo sapiens	21-24	
30422039-3	2019	While these trials do suggest that TPO-mimetics are efficacious at increasing platelet counts in patients with CLD and have led to several recent drug approvals in this space by the U.S. Food & Drug Administration, it remains unclear whether these results translate to the relevant clinical endpoint of reduced perioperative bleeding rate and severity.	Adenosine Monophosphate	193-196	thrombopoietin	Homo sapiens	35-38